IP Library › Assignment 065500/0944
Patent Assignment
Reel/Frame 065500/0944

Release of Security Interest

Recorded: 2023-11-08 Pages: 13
Assignor
PERCEPTIVE CREDIT HOLDING III, LP
Executed: 2023-07-28
Assignee
C4 THERAPEUTICS, INC.
490 ARSENAL WAY, SUITE 120, WATERTOWN, MASSACHUSETTS, 02472
Covered Properties (24)
Substituted Piperidine Degronimers for Target Protein Degradation
Application: 16/186,333 →
Publication: US 2019/0076539
Spirocyclic Degronimers for Target Protein Degradation
Application: 16/186,334 →
Publication: US 2019/0076540
Heterocyclic Degronimers for Target Protein Degradation
Application: 16/186,339 →
Publication: US 2019/0076541
C3-Carbon Linked Glutarimide Degronimers for Target Protein Degradation
Application: 16/186,341 →
Publication: US 2019/0076542
N/O-Linked Degrons and Degronimers for Protein Degradation
Application: 16/721,650 →
Publication: US 2020/0140456
Amine-Linked Degronimers for Targeted Protein Degradation
Application: 62/334,338 →
Spirocyclic Degronimers for Targeted Protein Degradation
Application: 62/334,130 →
Heterocyclic Degronimers for Targeted Protein Degradation
Application: 62/334,395 →
Carbon-Linked Degronimers for Targeted Protein Degradation
Application: 62/334,362 →
Degronimers for Targeted Protein Degradation
Application: 62/522,541 →
Degraders and Degrons for Targeted Protein Degradation
Application: 62/587,303 →
Cereblon Binders for the Degradation of Ikaros
Application: 62/648,238 →
Compounds for the Degradation of BRD9 or MTH1
Application: 62/726,667 →
Compounds for the Degradation of BRD9 or MTH1
Application: 62/779,319 →
Targeted Protein Degradation
Application: 62/783,004 →
Dihydrobenzimidazolones for Medical Treatment
Application: 16/809,325 →
Publication: US 2020/0207764
Glutarimides for Medical Treatment
Application: 16/809,336 →
Publication: US 2020/0207783
Dihydroquinolinones for Medical Treatment
Application: 16/809,345 →
Publication: US 2020/0207733
Heterocyclic Compounds
Application: 62/814,706 →
Tricyclic Cereblon Binders for the Degradation of Ikaros
Application: 62/833,107 →
Compounds for Targeted Degradation of BRD9
Application: 62/985,774 →
Heterocyclic Degronimers for Target Protein Degradation
Application: 16/872,225 →
Degraders and Degrons for Targeted Protein Degradation
Application: 16/874,475 →
Publication: US 2022/0251061
Spirocyclic Degronimers for Target Protein Degradation
Application: 16/882,236 →
Publication: US 2021/0106688
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 18, 2016
From: PHILLIPS, ANDREW J.; NASVESCHUK, CHRIS G.; HENDERSON, JAMES A.; LIANG, YANKE
To: C4 THERAPEUTICS, INC.
Reel/Frame 038632/0007 →
Assignment of Assignor's Interest May 18, 2016
From: PHILLIPS, ANDREW J.; NASVESCHUK, CHRIS G.; HENDERSON, JAMES A.; LIANG, YANKE
To: C4 THERAPEUTICS, INC.
Reel/Frame 038639/0889 →
Assignment of Assignor's Interest May 20, 2016
From: PHILLIPS, ANDREW J.; NASVESCHUK, CHRIS G.; HENDERSON, JAMES A.; LIANG, YANKE
To: C4 THERAPEUTICS, INC.
Reel/Frame 038658/0725 →
Assignment of Assignor's Interest May 20, 2016
From: PHILLIPS, ANDREW J.; NASVESCHUK, CHRIS G.; HENDERSON, JAMES A.; LIANG, YANKE
To: C4 THERAPEUTICS, INC.
Reel/Frame 038660/0591 →
Assignment of Assignor's Interest Feb 23, 2018
From: PHILLIPS, ANDREW J; NASVESCHUK, CHRISTOPHER G.; HENDERSON, JAMES A.; LIANG, YANKE
To: C4 THERAPEUTICS, INC.
Reel/Frame 045022/0573 →
Assignment of Assignor's Interest Jun 27, 2018
From: VEITS, GESINE KERSTIN; HE, MINSHENG; HENDERSON, JAMES A.; NASVESCHUK, CHRISTOPHER G.
To: C4 THERAPEUTICS, INC.
Reel/Frame 046215/0900 →
Assignment of Assignor's Interest Sep 13, 2018
From: PHILLIPS, ANDREW J.; NASVESCHUK, CHRISTOPHER G.; HENDERSON, JAMES A.; HE, MINSHENG
To: C4 THERAPEUTICS, INC.
Reel/Frame 046869/0598 →
Assignment of Assignor's Interest Nov 15, 2018
From: VEITS, GESINE KERSTIN; VORA, HARIT U.; NASVESCHUK, CHRISTOPHER G.; HENDERSON, JAMES A.
To: C4 THERAPEUTICS, INC.
Reel/Frame 047514/0775 →
Assignment of Assignor's Interest Jan 31, 2019
From: FITZGERALD, MARK E.; HE, MINSHENG; MICHAEL, RYAN E.
To: C4 THERAPEUTICS, INC.
Reel/Frame 048198/0036 →
Assignment of Assignor's Interest Feb 4, 2019
From: PHILLIPS, ANDREW J.; NASVESCHUK, CHRIS G.; HENDERSON, JAMES A.; LIANG, YANKE
To: C4 THERAPEUTICS, INC.
Reel/Frame 048225/0902 →
Assignment of Assignor's Interest Feb 4, 2019
From: FITZGERALD, MARK E.; HE, MINSHENG; MICHAEL, RYAN E.
To: C4 THERAPEUTICS, INC.
Reel/Frame 048226/0009 →
Assignment of Assignor's Interest Feb 4, 2019
From: PHILLIPS, ANDREW J.; NASVESCHUK, CHRIS G.; HENDERSON, JAMES A.; LIANG, YANKE
To: C4 THERAPEUTICS, INC.
Reel/Frame 048226/0019 →
Assignment of Assignor's Interest Feb 4, 2019
From: HE, MINSHENG; LAZARSKI, KIEL; VEITS, GESINE KERSTIN; VORA, HARIT U.
To: C4 THERAPEUTICS, INC.
Reel/Frame 048226/0035 →
Assignment of Assignor's Interest Feb 4, 2019
From: PHILLIPS, ANDREW J.; NASVESCHUK, CHRIS G.; HENDERSON, JAMES A.; LIANG, YANKE
To: C4 THERAPEUTICS, INC.
Reel/Frame 048225/0933 →
Assignment of Assignor's Interest Feb 4, 2019
From: LAZARSKI, KIEL; MICHAEL, RYAN E.
To: C4 THERAPEUTICS, INC.
Reel/Frame 048225/0954 →
Assignment of Assignor's Interest Feb 4, 2019
From: PHILLIPS, ANDREW J.; NASVESCHUK, CHRIS G.; HENDERSON, JAMES A.; LIANG, YANKE
To: C4 THERAPEUTICS, INC.
Reel/Frame 048225/0986 →
Assignment of Assignor's Interest Feb 4, 2019
From: CHEN, CHI-LI; DUPLESSIS, MARTIN; HE, MINSHENG; LAZARSKI, KIEL
To: C4 THERAPEUTICS, INC.
Reel/Frame 048225/0915 →
Assignment of Assignor's Interest May 14, 2019
From: VEITS, GESINE KERSTIN; VORA, HARIT U.; HENDERSON, JAMES A.; NASVESCHUK, CHRISTOPHER G.
To: C4 THERAPEUTICS, INC.
Reel/Frame 049177/0012 →
Assignment of Assignor's Interest May 20, 2019
From: HENDERSON, JAMES A.; HE, MINSHENG; GOOD, ANDREW CHARLES; PHILLIPS, ANDREW J.
To: C4 THERAPEUTICS, INC.
Reel/Frame 049230/0944 →
Assignment of Assignor's Interest Jul 30, 2019
From: PHILLIPS, ANDREW J; NASVESCHUK, CHRISTOPHER G.; HENDERSON, JAMES A.; JACKSON, KATRINA L.
To: C4 THERAPEUTICS, INC.
Reel/Frame 049907/0782 →
Corrective Assignment to Correct the Correct Assignee Address Previously Recorded at Reel: 048225 Frame: .915. Assignor(S) Hereby Confirms the Assignment. Sep 5, 2019
From: CHEN, CHI-LI; DUPLESSIS, MARTIN; HE, MINSHENG; LAZARSKI, KIEL
To: C4 THERAPEUTICS, INC.
Reel/Frame 050290/0179 →
Corrective Assignment to Correct the Correct Assignee Address Previously Recorded at Reel: 048225 Frame: 0902. Assignor(S) Hereby Confirms the Assignment. Sep 5, 2019
From: PHILLIPS, ANDREW J; NASVESCHUK, CHRIS G.; HENDERSON, JAMES A.; LIANG, YANKE
To: C4 THERAPEUTICS, INC.
Reel/Frame 050290/0039 →
Corrective Assignment to Correct the Correct Assignee Address Previously Recorded at Reel: 048225 Frame: 0933. Assignor(S) Hereby Confirms the Assignment. Sep 5, 2019
From: PHILLIPS, ANDREW J; HENDERSON, JAMES A.; LIANG, YANKE
To: C4 THERAPEUTICS, INC.
Reel/Frame 050289/0984 →
Corrective Assignment to Correct the Correct Assignee Address Previously Recorded at Reel: 048198 Frame: 0036. Assignor(S) Hereby Confirms the Assignment. Sep 5, 2019
From: FITZGERALD, MARK E.; HE, MINSHENG; MICHAEL, RYAN E.
To: C4 THERAPEUTICS, INC.
Reel/Frame 050289/0960 →
Corrective Assignment to Correct the Correct Assignee Address Previously Recorded at Reel: 048225 Frame: 0986. Assignor(S) Hereby Confirms the Assignment. Sep 5, 2019
From: PHILLIPS, ANDREW J.; NASVESCHUK, CHRIS G.; HENDERSON, JAMES A.; LIANG, YANKE
To: C4 THERAPEUTICS, INC.
Reel/Frame 050289/0831 →